Voxel-based whole-lesion enhancement parameters: a study of its clinical value in differentiating clear cell renal cell carcinoma from renal oncocytoma

PurposeThe purpose of this study was to compare whole-lesion (WL) enhancement parameters to single region of interest (ROI)-based enhancement in discriminating clear cell renal cell carcinoma (ccRCC) from renal oncocytoma.Materials and MethodsIn this IRB-approved retrospective study, the surgical database was queried to derive a cohort of 94 postnephrectomy patients with ccRCC or oncocytoma (68 ccRCC, 26 oncocytoma), who underwent preoperative multiphase contrast-enhanced computed tomography (CECT) between June 2009 and August 2013. CT acquisitions were transferred to a three-dimensional workstation, and WL ROIs were manually segmented. WL enhancement and histogram distribution parameters skewness, kurtosis, standard deviation (SD), and interquartile range (IQR) were calculated. WL enhancement parameters were compared to single ROI-based enhancement using receiver operating characteristic (ROC) analysis.ResultsOncocytoma had significantly higher WL enhancement than ccRCC in nephrographic (mean, p = 0.02; median, p = 0.03) and excretory phases (mean, p = 0.03; median p < 0.01). ccRCC had significantly higher kurtosis than oncocytoma in corticomedullary (p = 0.03) and excretory phases (p < 0.01), and significantly higher SD and IQR than oncocytoma in all postcontrast phases: corticomedullary (SD, p = 0.02; IQR, p < 0.01), nephrographic (SD, p = 0.01; IQR, p = 0.03), and excretory (SD, p < 0.01; IQR, p < 0.01). When compared to single ROI-based enhancement, WL enhancement alone did not demonstrate a statistical advantage in discriminating between ccRCC and oncocytoma (area under ROC curve of 0.78 and 0.72 respectively), but when combined with histogram distribution parameters (area under ROC curve of 0.86), it did demonstrate a slight improvement.ConclusionOur study suggests that voxel-based WL enhancement parameters provide only a slight improvement over single ROI-based enhancement techniques in differentiating between ccRCC and renal oncocytoma.

[1]  A. Hanlon,et al.  The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. , 2006, The Journal of urology.

[2]  J. McGahan,et al.  Is segmental enhancement inversion on enhanced biphasic MDCT a reliable sign for the noninvasive diagnosis of renal oncocytomas? , 2011, AJR. American journal of roentgenology.

[3]  R. Leveillee,et al.  Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography , 2011, World Journal of Urology.

[4]  E. Wallen,et al.  Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention. , 2007, The Journal of urology.

[5]  M. McInnes,et al.  Diagnostic accuracy of segmental enhancement inversion for diagnosis of renal oncocytoma at biphasic contrast enhanced CT: systematic review , 2014, European Radiology.

[6]  U. Kramer,et al.  Small renal oncocytomas: differentiation with multiphase CT. , 2011, European journal of radiology.

[7]  Berthold Kiefer,et al.  Histogram analysis of whole-lesion enhancement in differentiating clear cell from papillary subtype of renal cell cancer. , 2012, Radiology.

[8]  Choung-Soo Kim,et al.  Percutaneous Kidney Biopsy for a Small Renal Mass: A Critical Appraisal of Results. , 2016, The Journal of urology.

[9]  I. Sesterhenn,et al.  World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .

[10]  Christine O Menias,et al.  Benign renal neoplasms in adults: cross-sectional imaging findings. , 2008, AJR. American journal of roentgenology.

[11]  Kousei Ishigami,et al.  Imaging spectrum of renal oncocytomas: a pictorial review with pathologic correlation , 2014, Insights into Imaging.

[12]  Mesut Remzi,et al.  Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses. , 2008, European urology.

[13]  Michael A S Jewett,et al.  Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. , 2007, The Journal of urology.

[14]  R. Uzzo,et al.  Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review. , 2008, The Journal of urology.

[15]  P. Rogalla,et al.  Small renal oncocytomas: is segmental enhancement inversion a characteristic finding at biphasic MDCT? , 2012, AJR. American journal of roentgenology.

[16]  Hannu Huhdanpaa,et al.  Whole lesion quantitative CT evaluation of renal cell carcinoma: differentiation of clear cell from papillary renal cell carcinoma , 2015, SpringerPlus.

[17]  B. Trock,et al.  Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma. , 2012, Urology.

[18]  Chaya S Moskowitz,et al.  Solid renal cortical tumors: differentiation with CT. , 2007, Radiology.

[19]  E. Levine,et al.  Computed tomography of renal oncocytoma. , 1983, AJR. American journal of roentgenology.

[20]  R. Uzzo,et al.  Small renal masses progressing to metastases under active surveillance , 2012, Cancer.

[21]  M. Päivänsalo,et al.  Radiologic Findings in Renal Oncocytoma , 1991, Acta radiologica.

[22]  M. Lieber,et al.  Update on oncocytoma , 2003, Current urology reports.

[23]  K. Trpkov,et al.  Renal oncocytoma revisited: a clinicopathological study of 109 cases with emphasis on problematic diagnostic features , 2010, Histopathology.

[24]  J. Collins,et al.  A comparative study of metastatic renal cell carcinoma with correlation to subtype and primary tumor. , 2001, Pathology, research and practice.

[25]  T. Lebret,et al.  Percutaneous core biopsy for renal masses: indications, accuracy and results. , 2007, The Journal of urology.

[26]  P. Pierorazio,et al.  Active Surveillance for Small Renal Masses. , 2020, Reviews in urology.

[27]  A. Marx,et al.  World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs , 2004 .

[28]  Daniel Margolis,et al.  Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. , 2013, Radiology.

[29]  G. Glazer,et al.  Computed tomography of renal oncocytomas. , 1985, Computerized radiology : official journal of the Computerized Tomography Society.

[30]  A. Rajesh,et al.  Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms. , 2009, Clinical radiology.

[31]  Namkug Kim,et al.  CT histogram analysis: differentiation of angiomyolipoma without visible fat from renal cell carcinoma at CT imaging. , 2008, Radiology.

[32]  Victor E Reuter,et al.  The pathology of renal epithelial neoplasms. , 2006, Seminars in oncology.

[33]  Jung Im Kim,et al.  Segmental enhancement inversion at biphasic multidetector CT: characteristic finding of small renal oncocytoma. , 2009, Radiology.

[34]  F. Smedts,et al.  Core biopsies of renal tumors: a study on diagnostic accuracy, interobserver, and intraobserver variability. , 2008, European urology.

[35]  P. Russo,et al.  Metastatic renal cell carcinoma risk according to tumor size. , 2009, The Journal of urology.

[36]  Steven S Raman,et al.  Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses. , 2014, AJR. American journal of roentgenology.

[37]  L. Klotz,et al.  Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance. , 2011, European urology.

[38]  F. Fromowitz,et al.  Renal oncocytoma: new observations. , 1984, Radiology.